Characterization of natural human anti-non-Gal antibodies and their effect on activation of porcine Gal-deficient endothelial cells

Transplantation

Volumn 84, Issue 2, 2007, Pages 244-250

  Sæthre, Marit ^a,d   Baumann, Bettina C ^b   Fung, Michael ^c   Seebach, Jörg D ^b   Mollnes, Tom Eirik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Tanox Biosystems Inc   (United States)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute vascular rejection; Complement system; Immunoglobulin; Porcine endothelial cell; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; COMPLEMENT INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITOPE; GAL ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CELL ACTIVATION; CELL SURFACE; COMPARATIVE STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMORAL IMMUNE DEFICIENCY; MALE; NONHUMAN; ORGAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SWINE; UPREGULATION; XENOGRAFT;

ADULT; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; AORTA; CELL TRANSPLANTATION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CULTURE MEDIA, CONDITIONED; DISACCHARIDES; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 34547643527     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000268815.90675.d5     Document Type: Article

References (43)

1. Oriol R, Ye Y, Koren E, Cooper DK. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
2. Galili U. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 1993; 15: 155.
3. Galili U. The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie 2001; 83: 557.
4. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
5. Xu Y, Lorf T, Sablinski T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65: 172.
6. Lucchiari N, Azimzadeh A, Wolf P, et al. In vivo and in vitro optimization of depletion of IgM and IgG xenoantibodies by immunoadsorption using cell membrane proteins. Artif Organs 1997; 21: 278.
7. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423.
8. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
9. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
10. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089.
11. Kuwaki K, Knosalla C, Dor FJ, et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human antihuman CD154 mAb-based regimen. Am J Transplant 2004; 4: 363.
12. Chen G, Sun H, Yang H, et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006; 81: 273.
13. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295.
14. Platt JL, Lin SS, McGregor CG. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
15. Higashi H, Naiki M, Matuo S, Okouchi K. Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 1977; 79: 388.
16. Merrick JM, Zadarlik K, Milgrom F. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing n-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 1978; 57: 477.
17. Bouhours D, Pourcel C, Bouhours JE. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J 1996; 13: 947.
18. Morozumi K, Kobayashi T, Usami T, et al. Significance of histochemical expression of Hanganutziu-Deicher antigens in pig, baboon and human tissues. Transplant Proc 1999; 31: 942.
19. Marquina G, Waki H, Fernandez LE, et al. Gangliosides expressed in human breast cancer. Cancer Res 1996; 56: 5165.
20. Miyoshi I, Higashi H, Hirabayashi Y, et al. Detection of 4-O-acetyl-N-glycolylneuraminyl lactosylceramide as one of tumor-associated antigens in human colon cancer tissues by specific antibody. Mol Immunol 1986; 23: 631.
21. Morito T, Kano K, Milgrom F. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases. J Immunol 1982; 129: 2524.
22. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 2003; 100: 12045.
23. Miwa Y, Kobayashi T, Nagasaka T, et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004; 11: 247.
24. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9: 376.
25. Kobayashi T, Yokoyama I, Suzuki A, et al. Lack of antibody production against Hanganutziu-Deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history. Xenotransplantation 2000; 7: 177.
26. Saethre M, Solvik UO, Haraldsen G, et al. Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies. Xenotransplantation 2002; 9: 350.
27. Saethre M, Lea T, Borgen MS, et al. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation. Xenotransplantation 2006; 13: 215.
28. Baumann BC, Stussi G, Huggel K, et al. Reactivity of human natural antibodies to endothelial cells from Galα(1,3)-deficient pigs. Transplantation 2007; 83: 193.
29. Stussi G, Huggel K, Lutz HU, et al. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005; 130: 954.
30. Seebach JD, Schneider MK, Comrack CA, et al. Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 2001; 8: 48.
31. Baumann BC, Forte P, Hawley RJ, et al. Lack of galactose-alpha-1, 3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 2004; 172: 6460.
32. Fung M, Lu M, Fure H, et al. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage. Clin Exp Immunol 2003; 133: 160.
33. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29.
34. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3- galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32.
35. Gollackner B, Goh SK, Qawi I, et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004; 77: 1735.
36. Lam TT, Paniagua R, Shivaram G, et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004; 11: 531.
37. Hara H, Ezzelarab M, Rood PP, et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans. Xenotransplantation 2006; 13: 357.
38. Palmetshofer A, Galili U, Dalmasso AP, et al. Alpha-galactosyl epitopemediated activation of porcine aortic endothelial cells: type II activation. Transplantation 1998; 65: 971.
39. Solvik UO, Haraldsen G, Fiane AE, et al. Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated. Transplantation 2001; 72: 1967.
40. Baumann BC, Schneider MK, Lilienfeld BG, et al. Endothelial cells derived from pigs lacking Gal alpha(1,3)Gal: No reduction of human leukocyte adhesion and natural killer cell cytotoxicity. Transplantation 2005; 79: 1067.
41. Tseng YL, Kuwaki K, Dor FJ, et al. alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
42. Milland J, Christiansen D, Lazarus BD, et al. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 2006; 176: 2448.
43. Sharma A, Naziruddin B, Cui C, et al. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003; 75: 430.